Brian Eliceiri

Title: Brian Eliceiri: Innovator in Angiogenesis Modulation

Introduction

Brian Eliceiri is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of angiogenesis modulation, holding 2 patents that focus on innovative methods and compositions.

Latest Patents

His latest patents include "Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src." This invention describes methods for modulating angiogenesis in tissues using Src protein, modified Src protein, and nucleic acids encoding for such. The invention particularly focuses on inhibiting angiogenesis using an inactive Src protein or nucleic acids encoding therefor, as well as potentiating angiogenesis using an active Src protein. Additionally, it discusses the use of gene delivery systems for providing nucleic acids encoding for the Src protein or its modified forms. Another patent is titled "Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases." This invention outlines methods for modulating vascular permeability in tissues using Src or modified Src protein, Yes protein, or modified Yes protein, along with nucleic acids capable of expressing such proteins.

Career Highlights

Brian Eliceiri has worked at prestigious institutions such as The Scripps Research Institute and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has significantly advanced the understanding of angiogenesis and vascular permeability.

Collaborations

He has collaborated with notable colleagues, including David A Cheresh and Pamela L Schwartzberg, contributing to the advancement of research in his field.

Conclusion

Brian Eliceiri's innovative work in angiogenesis modulation has led to valuable patents that enhance our understanding of vascular processes. His contributions continue to impact the scientific community and pave the way for future research.